Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$82,495.23
Dec 1, 2020
Aboriginal recipient
Contribution Agreement
-
Strategic priority for firearms safety training.
$303,189.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
158036
The specific objective of this funding opportunity is:
•to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that will further advance the respective research areas.
$326,847.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
158037
The specific objective of this funding opportunity is:
•to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that will further advance the respective research areas.
$281,970.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
158038
The specific objective of this funding opportunity is:
•to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that will further advance the respective research areas.
$6,000,000.00
Dec 1, 2020
Individual or sole proprietorship
Op Gr: Network of Clinical Trials Networks: COVID-19 and Intervention Strategies
158424
Applications must ensure relevance to all of the following objectives:
• Establish central coordination and collaboration activities with existing clinical trials groups/networks to increase the availability of high-quality and real-time evidence and build capacity to support Canada’s rapid response to the global pandemic and health emergencies in order to better prevent, detect, treat and/or manage COVID-19;
• Establish a transparent, inclusive, multi-jurisdictional recruitment and membership process that describes benefits for and requirements and expectations of members;
• Collaborate across member networks to establish resource and data sharing policies, increase efficiencies in research and related processes (including, but not limited to ethics review; contracts; common protocols; developing applications for trial funding; consistent and valid patient-oriented outcomes), reduce duplication, and maximize research impact for COVID-19;
• Create data sharing agreements to ensure follow-up of patients through existing administrative data platforms within Canada;
• Adopt a nimble and adaptive strategy for engaging stakeholders in research prioritization and oversight while shifting studies as needed, based on new knowledge and changing COVID-19 landscape;
• Provide evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and across jurisdictions in Canada and internationally; and
• Enhance local, national and/or international clinical trial collaborative efforts by aligning clinical trials networks with other COVID-19 research investments to prevent and/or mitigate the rapid spread of COVID-19 and related negative consequences.
$1,199,987.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: CLSA COVID-19 Module
158379
The specific objectives of this directed grant are to support the:
• Collection of data from CLSA participants;
• Revision of the COVID-19 questionnaire as the pandemic evolves in the coming months;
• Generation of an electronic dataset that will be made available on the CLSA platform
$1,494,952.00
Dec 1, 2020
Individual or sole proprietorship
Team Grant: CIHR-JDRF-Accelerating Stem Cell-Based Therapies for Type 1 Diabetes
157957
The specific objectives of this funding opportunity are:
• To strengthen and create new, Canadian-led multidisciplinary collaborations among researchers working in stem cell biology, immunology and related fields to advance knowledge and technologies relevant to beta cell replacement in T1D.
• To accelerate potential stem cell-based therapies for T1D to the preclinical or clinical trial stage.
$353,000.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: Active and Assisted Living Program
158318
The specific objectives of this funding opportunity are:
-Developing, testing, validating, scaling up and integrating innovative ICT solutions for ageing well into re-designed service delivery models aimed at maintaining long term “functional ability” (See Call rationale and WHO Healthy ageing definition);
-Contributing to the creation/strengthening/connection of healthy ageing ecosystems.
$1,000,000.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 Knowledge Synthesis Network
158359
The objective of this funding opportunity is to support a knowledge synthesis network designed to collaborate and rapidly respond to the need for synthesized evidence across the full breadth of Canada's COVID-19 pandemic response (including public-health measures, clinical management, health-system arrangements, and economic and social impacts). Through a highly collaborative approach, the knowledge synthesis network is expected to:
-Produce rapid knowledge syntheses and associated evidence-based products (e.g., evidence profiles) related to the COVID-19 pandemic, based on current evidence and that responds to an identified evidence need;
-Provide decision-makers with high-quality, timely, accessible and relevant evidence for the rapid translation of knowledge into policy, practice and/or clinical guidelines to address the immediate response to the pandemic; and
-Address evidence gaps and build the evidence base for the response to COVID-19;
-Enhance national and international coordination across knowledge synthesis experts and organizations involved in producing COVID-19 related products.
$1,500,000.00
Dec 1, 2020
Individual or sole proprietorship
Team Grant: CIHR-JDRF-Accelerating Stem Cell-Based Therapies for Type 1 Diabetes
157956
The specific objectives of this funding opportunity are:
• To strengthen and create new, Canadian-led multidisciplinary collaborations among researchers working in stem cell biology, immunology and related fields to advance knowledge and technologies relevant to beta cell replacement in T1D.
• To accelerate potential stem cell-based therapies for T1D to the preclinical or clinical trial stage.